Nitroglycerin Transdermal System
Product Images NDC 68382-310

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Nitroglycerin Transdermal System (NDC 68382-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 01)

Chemical structure diagram showing a molecular formula with three CONO2 groups and hydrogen atoms. This likely represents the chemical structure of the active ingredient in Nitroglycerin Transdermal System by Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 02)

Packaging label for Nitroglycerin Transdermal System 0.2 mg/hr, distributed by Zydus Pharmaceuticals USA Inc. The label indicates the product contains 30 systems with each delivering 0.2 mg/hr of nitroglycerin via a transdermal patch. It includes instructions for applying the patch, storage conditions, and manufacturer details (Hercon Pharmaceuticals, LLC). The label features a barcode and usage directions emphasizing prescription use only.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 03)

Packaging label for Nitroglycerin Transdermal System 0.4 mg/hr by Zydus Pharmaceuticals USA Inc. The label indicates a supply of 30 systems with an approximate rated release of 0.4 mg/hr for transdermal use. It includes usage instructions with illustrations, storage conditions, manufacturer information (Hercon Pharmaceuticals, LLC), and a barcode. The designation is Rx only.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 04)

Packaging label for Nitroglycerin Transdermal System 0.6 mg/hr by Zydus Pharmaceuticals USA Inc. The label indicates a box of 30 systems with instructions for use, usual dosage information, storage conditions, and manufacturer details. The product is for transdermal use only, with a rated release of 0.6 mg/hr nitroglycerin per 21 cm2 patch.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 100 2)

An illustration showing the end of a transdermal patch being applied or peeled off from the skin, with lines suggesting the release or absorption of the active ingredient through the skin layers.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 100 3)

An illustration showing a hand holding a round transdermal patch, likely the Nitroglycerin Transdermal System, demonstrating removal or application. The patch has tab lines suggesting peel-away layers.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 2)

Instructional illustration showing hands peeling back the protective liner of a Nitroglycerin Transdermal System patch. This diagram demonstrates how to open the patch packaging or prepare the patch for application.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 3)

An instructional diagram showing hands holding a circular transdermal patch with an arrow indicating the direction to peel or open the patch.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 4)

An instructional illustration showing two hands peeling apart the layers of a transdermal patch, likely demonstrating how to prepare or apply the Nitroglycerin Transdermal System patch. The image focuses on the removal of the patch's protective films.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 5)

An instructional illustration showing a hand holding a circular transdermal patch, partially peeled away from its backing, demonstrating how to remove or apply the patch.*

FDA Label Image

Image (B8034ea3 Aac2 4a33 8482 D977b1dc8eb7 97 6)

An instructional illustration showing two steps of applying a Nitroglycerin Transdermal System patch. The left side depicts a hand holding the round patch near the skin, and the right side shows fingers pressing the patch onto the skin to ensure adhesion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.